The disrupted balance of antioxidant production and increased ROS production further elevate levels of inflammatory factors such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and IL-8, all of which can further stimulate NF-κB activation, thereby promoting cancer occurrence and progression (3, 34, 40). Here, IL6 is linked to cancer.